| A Nov 25 article in the NY Times calls Connecticut "Stem Cell Central." The work of UConn's David Rowe and Ren-He Xu, and Yale's Haifan Lin and Michael Snyder, is noted. more |
| 2/7 Alternative Products and Green Chemistry: Challenges and Opportunities of the New Global Marketplace. Northeast Utilities Conference Center, Berlin, CT. more |
| 2/12 3:00 pm - 6:00 pm. CURE and Yale OCR Present: Rib-X. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT. Reception and networking to follow. Watch for details. |
| 3/19 3:00 pm - 6:00 pm. CURE and Yale OCR Present: Optherion. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT. Reception and networking to follow. Watch for details. |
| 3/26 Connecticut Innovations Annual Technology Celebration. The Aqua Turf Club, Southington, CT. more |
| 4/11 8:00 am - 6:30 pm. Healthcare 2008 at the Yale School of Management. "Whose Healthcare is it Anyway? Understanding the Patient as a Consumer." Omni Hotel, New Haven, CT. more |
| 4/16 3:30 pm - 6:00 pm. CURE and Yale OCR Present: The Next Big Idea - Creating a New Venture. A Special BioHaven Entrepreneurship Panel with Roger Longman of Windhover Publications. Reception and networking to follow. Anlyan Center, Congress Avenue, New Haven, CT. Watch for details. |
| 4/23 3:00 pm - 6:00 pm. CURE and Yale OCR Present: Vidus Ocular. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT. Reception and networking to follow. Watch for details. |
|  |
|
|
Stem Cell Breakthroughs Make the News
From the desk of Paul Pescatello, President and CEO of CURE
 Last month I wrote that Connecticut’s wise decision to embrace stem cell research was continuing to pay dividends. In the past few weeks, breaking news attests even further to the wisdom of that decision. To begin with, Haifan Lin and his stem cell center at Yale have succeeded in attracting another of the world's leading bioscientists to our state. Meanwhile, those following stem cell research were fascinated to read of experiments that point towards a promising alternative route to generating stem cells.
For the full story
|
BioRelix & Vascular Insights Launch BioHaven Series
 The Yale BioHaven Entrepreneurship Series, presented by CURE and Yale OCR, launched its 2007-2008 schedule with presentations by two local Yale spin-outs: BioRelix, which is developing antibiotics that target microbial RNA, and Vascular Insights, which will market a new device for treating varicose vein disease.
For the full story
|
CURE Member News Digest
 454 Life Sciences announces publication of over 100 studies
Achillion reports on 3Q progress
Alexion named winner of CURE Award of Excellence
Bayer HealthCare reports Nexavar® approval
Boehringer Ingelheim named top employer
Bristol-Myers Squibb reports AVALIDE® progress
Cara Therapeutics marks Shelton opening
Connecticut Innovations names board members
CuraGen comments on 3Q position
Genomas reports pain research
GlaxoSmithKline changes Avandia® label
Hartford Hospital gets organ donation recognition
HistoRx to use funding for AQUA® platform
Invitrogen benefits from defense bill
Ipsogen announces mutation tool kit
Johnson & Johnson reports ZYRTEC® approval
MannKind continues with inhalable insulin
NanoViricides reports rabies progress
Neurogen foresees advances in 4Q
Pfizer to acquire Coley Pharmaceutical Group
PhRMA reports on fight against staph infections
Discovery magazine cites Protein Sciences Corporation vaccine
Rib-X to present at Feb 12 BioHaven
VaxInnate gains from defense bill
Vion confirms Cloretazine® goals
Winstanley buys 25 Science Park
UConn names professor to BI endowed chair
Yale gets funding for cancer center
For the full story
|
|
|
